Sectra sees rise in sales during fiscal Q1
Swedish medical systems developer Sectra saw an increase in net sales for fiscal Q1 2006 of 33.8 percent to approximately $18.5 million (USD) compared with the year-earlier period. Profit for the company increased by 2.0 percent to approximately $ 2 million, which corresponds to a profit margin of 3.7 percent, the company said.
Increased revenues from direct sales of medical systems in the United States and the completion of the digitization at the Karolinska University Hospital, one of the largest hospitals in the Nordic region, contributed to the quarter's increase in net sales, the company said.
"Direct sale of medical systems in the market outside Scandinavia has gradually increased during the past six months as a result of our ongoing market investments," says Jan-Olof Brüer, CEO and president, Sectra AB.
Sectra also stated that there is there is an ongoing clinical study in the United States of its digital mammography system, Sectra MicroDose Mammography. During the first quarter, data acquisition for the study was completed. This places Sectra one step closer to an application for approval from the FDA.
Increased revenues from direct sales of medical systems in the United States and the completion of the digitization at the Karolinska University Hospital, one of the largest hospitals in the Nordic region, contributed to the quarter's increase in net sales, the company said.
"Direct sale of medical systems in the market outside Scandinavia has gradually increased during the past six months as a result of our ongoing market investments," says Jan-Olof Brüer, CEO and president, Sectra AB.
Sectra also stated that there is there is an ongoing clinical study in the United States of its digital mammography system, Sectra MicroDose Mammography. During the first quarter, data acquisition for the study was completed. This places Sectra one step closer to an application for approval from the FDA.